This is a working overview of gastric juice protein, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-02-07 and is reviewed periodically as new material appears.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | computed for the free peptide |
| Molecular weight | about 1419 Da | monoisotopic mass near 1418.7 |
| Amino acid count | 15 | single chain, no disulfide bonds |
| Solubility | freely soluble in water | also dissolves in saline and phosphate buffer |
| Common synonyms | pentadecapeptide BPC, BPC 157 | fragment notation varies by source |
Material of this kind is sold for laboratory research, and labels typically state that it is not intended for human or veterinary use. In many countries it is not an approved medicine, and sports antidoping rules place it among prohibited non-approved substances. Buyers commonly review a certificate of analysis, an independent test report, and the declared storage conditions. Batch-to-batch variation in purity and in counterion content is possible, and how much that variation affects experimental outcomes remains an open question.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
The Clip Editor; for recording, editing, and arranging shots. They hold the user's recorded gameplay and virtual assets. It also allows the user to place and arrange sound files and video filters. The Motion Editor; for motion adjustments over time such as blending two animations. Users can also use motion presets to select paths and manipulate different scene objects, play clips at different times, and puppeteer the characters in different positions and frames. The Graph Editor; for editing motion by creating keyframes that can be used for pose-to-pose animation. Users can either create new projects or import data from Source-based games to extend their SFM animations. SFM also supports several cinematographic effects and techniques such as motion blur, Tyndall effects, dynamic lighting, and depth of field. Users can also use inverse kinematics to manually animate movements. More advanced users can use Source's official modding tools to create environments, import new models and characters, change textures, and make scripts that make their workflow easier.
== Mechanism of action == Alpha-glucosidase inhibitors are saccharides that act as competitive inhibitors of enzymes needed to digest carbohydrates: specifically alpha-glucosidase enzymes in the brush border of the small intestines. The membrane-bound intestinal alpha-glucosidases hydrolyze oligosaccharides, trisaccharides, and disaccharides to glucose and other monosaccharides in the small intestine. Acarbose also blocks pancreatic alpha-amylase in addition to inhibiting membrane-bound alpha-glucosidases. Pancreatic alpha-amylase hydrolyzes complex starches to oligosaccharides in the lumen of the small intestine. Inhibition of these enzyme systems reduces the rate of digestion of carbohydrates. Less glucose is absorbed because the carbohydrates are not broken down into glucose molecules. In diabetic patients, the short-term effect of these drugs therapies is to decrease current blood glucose levels: the long-term effect is a small reduction in hemoglobin A1c level.
By September 2014, Houthis were said to control parts of the Yemeni capital, Sanaa, including government buildings and a radio station. While Houthi control expanded to the rest of Sanaa, as well as other towns such as Rada', this control was strongly challenged by Al-Qaeda. The Gulf States believed that the Houthis had accepted aid from Iran while Saudi Arabia was aiding their Yemeni rivals. On 20 January 2015, Houthi rebels seized the presidential palace in the capital. President Abdrabbuh Mansur Hadi was in the presidential palace during the takeover but was not harmed. The movement officially took control of the Yemeni government on 6 February, dissolving parliament and declaring its Revolutionary Committee to be the acting authority in Yemen. On 20 March the al-Badr and al-Hashoosh mosques came under suicide attack during midday prayers, and the Islamic State quickly claimed responsibility. The blasts killed 142 Houthi worshippers and wounded more than 351, making it the deadliest terrorist attack in Yemen's history. On 27 March 2015, in response to perceived Houthi threats to Sunni factions in the region, Saudi Arabia along with Bahrain, Qatar, Kuwait, UAE, Egypt, Jordan, Morocco, and Sudan led a gulf coalition airstrike in Yemen. The military coalition included the United States which helped in planning of airstrikes, as well as logistical and intelligence support.
Potato dishes vary around the world. Peruvian cuisine naturally contains the potato as a primary ingredient in many dishes, as around 3,000 varieties of the tuber are grown there. Chuño is a freeze-dried potato product traditionally made by Quechua and Aymara communities of Peru and Bolivia. In the UK, potatoes form part of the traditional dish fish and chips. Roast potatoes are commonly served as part of a Sunday roast dinner and mashed potatoes form a major component of several other traditional dishes, such as shepherd's pie, bubble and squeak, and bangers and mash. New potatoes may be cooked with mint and are often served with butter. In Germany, Northern Europe (Finland, Latvia and especially Scandinavian countries), Eastern Europe (Russia, Belarus and Ukraine) and Poland, newly harvested, early ripening varieties are considered a special delicacy. Boiled whole and served un-peeled with dill, these "new potatoes" are traditionally consumed with Baltic herring. Puddings made from grated potatoes (kugel, kugelis, and potato babka) are popular items of Ashkenazi, Lithuanian, and Belarusian cuisine. Cepelinai, the national dish of Lithuania, are dumplings made from boiled grated potatoes, usually stuffed with minced meat. In Italy, in the Friuli region, potatoes serve to make a type of pasta called gnocchi. Potato is used in northern China where rice is not easily grown, a popular dish being 青椒土豆丝 (qīng jiāo tǔ dòu sī), made with green pepper, vinegar and thin slices of potato. In the winter, roadside sellers in northern China sell roasted potatoes.
In 2016, Tim Hortons announced that they would be opening stores in the United Kingdom starting in 2017. Glasgow saw the first UK store open its doors on June 2, 2017, with a further store opening in Bishopbriggs in November 2017. In November 2017, two stores in Cardiff opened, as well as a store opening in Dunfermline. In December 2017, two further stores were opened in Trafford in the towns of Sale and Altrincham. On December 20, 2017, the chain opened a store in the Golden Square Shopping Centre in Warrington. Tim Hortons opened its first two stores in Northern Ireland in 2018: one on Fountain Street in Belfast city centre, and another drive-thru store at the Connswater Retail Park in East Belfast. With the opening of the Braintree and Stockport (Greater Manchester) branches in February 2022, Tim Hortons had 47 locations in the United Kingdom. By January this had increased to 73 locations, with at least a further three locations in development. In March 2023 they opened a branch in Westwood Cross in Thanet, Kent. The first Tim Hortons location in the Republic of Ireland was reported to be opening in Limerick in 2022, however this did not materialize.
Sources: en.wikipedia.org
One study found that "launch prices" for new drugs became approximately 50% higher over the three-year period from 2022 to 2024 (inclusive), with an expert saying this practice is likely to continue until it receives a policy response.
=== Precursor of Others === Arginine is also a precursor for urea, ornithine, and agmatine; is necessary for the synthesis of creatine; and can also be used for the synthesis of polyamines (mainly through ornithine and to a lesser degree through agmatine, citrulline, and glutamate). The presence of asymmetric dimethylarginine (ADMA), a close relative, inhibits the nitric oxide reaction; therefore, ADMA is considered a marker for vascular disease, just as L-arginine is considered a sign of a healthy endothelium. In mammals, arginine can be converted into proline via glutamate-5-semialdehyde and pyrroline-5-carboxylic acid. The conversion of arginine into other amino acids also occurs in bacteria; for example, species of the genus Bacillus can convert arginine into proline or glutamic acid via ornithine. The Solanum alkaloids (from the plant family Solanaceae) and Veratrum alkaloids (genus Veratrum) are synthesized from cholesterol via biosynthesis. Nitrogen is introduced from arginine through transamination. Vargulin is a luciferine formed by shellfish from arginine, tryptophan, and isoleucine, and is used to produce bioluminescence in the form of blue light. During bioluminescence, the reaction of a luciferin with a luciferase generates an energetically excited molecule that emits light. Vargulin is found in the genera Vargula and Cypridina, as well as in certain fish species that consume shellfish and acquire the compound through their diet.
==== 1996 kimchi standard dispute with Japan ==== In 1996, Korea protested against Japanese commercial production of kimchi arguing that the Japanese-produced product (kimuchi, キムチ) was different from kimchi. In particular, Japanese kimchi was not fermented and was more similar to asazuke. Korea lobbied for an international standard from the Codex Alimentarius, an organization associated with the World Health Organization that defines voluntary standards for food preparation for international trade purposes. In 2001, the Codex Alimentarius published a voluntary standard defining kimchi as "a fermented food that uses salted napa cabbages as its main ingredient mixed with seasonings, and goes through a lactic acid production process at a low temperature", but which neither specified a minimum amount of fermentation nor forbade the use of any additives. Following the inclusion of the kimchi standard, kimchi exports in Korea did increase, but so did the production of kimchi in China and the import of Chinese kimchi into Korea.
== Fourth ministry == On 23 December 1974, following the 1974 election on 7 December, the Ministry was reconstituted, and served until a reshuffle on 13 August 1976. Sir Alan Fletcher and Douglas Tooth retired from politics and left the ministry, while Wally Rae was appointed Agent-General of Queensland on 6 December. They were replaced by Tom Newbery, Ken Tomkins and Llew Edwards. On 10 March 1975, the ministry grew from 14 to 18 offices.
Angelica sinensis, commonly known as dong quai (simplified Chinese: 当归; traditional Chinese: 當歸; pinyin: dāngguī; Jyutping: dong1 gwai1; Pe̍h-ōe-jī: tong-kui) or female ginseng, is a herb belonging to the family Apiaceae, indigenous to China. A. sinensis grows in cool high altitude mountains in East Asia. There is no scientific evidence that A. sinensis is effective for any medicinal purpose.
Sources: en.wikipedia.org
The sequence corresponds to a fragment of a protein found in human gastric juice, so related sequences are natural. The isolated fifteen-amino-acid peptide supplied for research is produced synthetically. Whether the free fragment circulates naturally in humans has not been settled.
In most jurisdictions it is not an approved medicine and is handled as a research material. Import and sale rules differ by country, and some regulators have placed it in categories that restrict human use. Status can change, so current local rules apply.
Rodent models dominate, particularly rats with induced gastric lesions, tendon injury, or vascular disruption. These designs allow controlled comparison but differ anatomically and metabolically from humans. Results from such models are commonly cited as preliminary.
The peptide is synthetic, but its sequence matches a segment of a protein present in human gastric juice. It does not occur as a free fifteen-residue peptide in the body.